RecruitingNCT07537517

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.

Studying Heritable pulmonary arterial hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital General Universitario Gregorio Marañon
Principal Investigator
Ana I Fernandez-Avila, PhD
Institoto de Investigación Gregorio Marañón
Enrollment
150 enrolled
Eligibility
18 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

Fundacion para la Innovacion en Biomedicina (FIBMED) · Instituto de Investigación Sanitaria Gregorio Marañón

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07537517 on ClinicalTrials.gov

Other trials for Heritable pulmonary arterial hypertension

Additional recruiting or active studies for the same condition.

See all trials for Heritable pulmonary arterial hypertension

← Back to all trials